Tuesday, 10 December 2019

Prima-Temp announces new leadership, investment and CE Mark certification

03 May 2019 | News

The Priya Sensor was developed to overcome the limitations of current fertility detection methods, designed to predict the pre-ovulatory period of time most favorable for achieving pregnancy

Prima-Temp, Inc. a developer and manufacturer of AI-assisted fertility management products, has announced  that in March, it raised $5M in new funding from the Hungarian pharmaceutical company Gedeon Richter, and in April achieved CE mark certification for its Priya Fertility Sensor product.

Prima-Temp's new President and CEO, Steve Hane, led the fundraising effort. "I was very excited to join Prima-Temp earlier this year, and am now even more enthused with the news of these pivotal investment and certification events," said Hane. "Prima-Temp's approach to continuous core body temperature monitoring as a correlative factor to fertility prediction is just the first step on a broader approach to developing a digital chronobiology platform for creating better health outcomes for women. Combining our European partnership with Gedeon Richter, and CE mark certification for Priya, we're well-positioned for an exciting future."

"This funding support of Prima-Temp is a clear sign of our commitment towards our partner, and it proves our trust in the device under development. In our view, female fertility is a paramount market within women's healthcare, which is our core business," said Gabor Orban, Chief Executive Officer of Gedeon Richter.

The Priya Sensor was developed to overcome the limitations of current fertility detection methods, designed to predict the pre-ovulatory period of time most favorable for achieving pregnancy. Priya is an intravaginal, flexible medical-grade ring form-factor that continuously measures and records core body temperature (CBT). The sensor transmits this data wirelessly to the Priya App, for the proprietary algorithm to predict the fertile window, providing an empowering and effortless fertility management experience.

CBT is widely recognized by circadian researchers as a cornerstone measurement for correlating to a wide variety of health-related indications, beyond fertility and into realms of clinical decision support in many areas like sleep disorders, sepsis detection, and oncology.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls